Thursday , April 9 2020
Home / argentina / Bronchiolitis successfully passed the test of an experimental vaccine in pregnant Argentina

Bronchiolitis successfully passed the test of an experimental vaccine in pregnant Argentina


vaccine bronchiolitisTo apply mothers pass antibodies to their children through the placenta, it has been tested with good response in pregnant women in some countries, including Argentina, According to local doctors who participated in the study.

Although there are in the world several groups of scientists working on the development of vaccines respiratory syncytial virus (RSV)What causes the bronchial tubes, the specificity of this study, which is nearing completion, should be applied to the mother to protect the child, especially during the first three months of life, when the disease can be more serious & # 39; oznay.

"Since BPC does not change, as it happens, for example, the vaccine against influenza that requires a new vaccine every year boys will be immunized at birth and during the first months of lifeWhich when most in need of protection, "emphasized by Infant Foundation, a non-governmental organization established by the Argentine doctor who studies the causes of respiratory disease in children and is involved in a study of a new dose.

How were the tests

The vaccine is injected in the recent 40 pregnant women attending a military hospital in Buenos Aires and more than 200 in Tucuman and Salta, and the results were "excellent". "It became pregnant to see if the antibodies transferred children who have not yet developed a good immune response," said deputy chief physician Department maternal and child health center of Buenos Aires, Gonzalo Perez Marc (MN 110813).

The specialist said that in 40 pregnant women in the city of Buenos Aires "antibody generation was excellent".

"Now we have to look after children and wait for assessments of regulatory bodies in the world, which takes at least a few years and then see if in order to achieve the purpose of protecting, You can be added to the immunization schedule"Marc Perez is completed.

Fernando Polack at this time (MN 83428), Director of the Child, said that "There is currently no specific treatment for this disease"" The study of the vaccine for bronchiolitis, participating in the final stage of evaluation of Argentina, the US, New Zealand, the Philippines and South Africa, a well-developed, "he added.

Main respiratory infections in children under two years old

Angela Gentile (MN 49908), epidemiology director of the Children's Hospital Ricardo Gut & # 39; ERES and former president of the Argentine Pediatric Society (SAP), said that "even though two-thirds of up to two years, may be affected by the virus, the state does not attack all the same" . "We are concerned about the most vulnerable children, ie premature babies or babies with low birth weight with certain lung diseases for mechanical ventilation for a long time, as well as children with congenital heart disease. This population is four to five times greater risk of hospitalization for RSV infection as compared to healthy boys, "he said.

In Argentina, the annual peak incidence, It begins with a cold, and two or three days of symptoms such as shortness of breath, fatigue, fever or chest breathing subsidence occurs in the period from May to August, This is the main respiratory infection in children under two years of age and the leading cause of death in children between one month and one year. According to the Ministry of health of the nation, during 2017 were registered 283.828 and 226.835 cases up to 46 weeks in 2018.

In addition, statistics Argentina Society of Pediatrics in 2016 showed that 740 children under the age of two, died of bronchitis.

Regarding prevention current only approved interference with severe RSV disease with & # 39 is an antibody directed to a very specific population (Premature heart disease and high-risk children) and has a high cost. The path of infection through direct contact with contaminated hands with a runny nose, coughing or sneezing sick person.

Source link